Dossier
Series B round
Coverage of Series B round in the Nexus archive.
- Triomics nabs $22M to bring oncology-specific AI to cancer centers
Triomics secured $22 million in a Series B funding round led by Battery Ventures to develop oncology-specific AI tools for cancer centers. The investment aims to advance AI-driven solutions tailored to oncology care.